2025 - 26, VACCINE UPDATE
Boosting
community
immunity,
one vaccination at a time.
VACCINES WE OFFER
- 2025-2026 Comirnaty (Pfizer)
- 2025-2026 Influenza (High Dose And Regular Dose)
- Meningits
- Pneumonia
- RSV - Respiratory Synctial Virus
- Shingrix (Shingles)
- T-Dap
- Typhoid
2025 Flu & Updated COVID-19 Vaccines are in.
As per New York State in regards to COVID Vaccines:
"All adults 19-64 years are recommended to be vaccinated against COVID-19. All adults 65 years and older should be vaccinated."
No prescription or appointment required - check our walk-in hours for November, 2025. If you need more information on vaccines, or would like to book an appointment - fill out the form fields below.
Where we are
485 Tuckahoe Road, Yonkers NY 10710
valuepluspharmacy@gmail.com
Phone number
914-961-1185 ext 1
FAQ
If you are interested in any of the vaccines, you can call us at 914-961-1185 ext 1 or fill out the form below and the team at ValuePlus will contact you within 1 business day.

RSV -Respiratory Synctial Virus
The new RSV vaccine offers a promising defense against respiratory syncytial virus (RSV) for individuals aged 60 years and older. RSV can lead to severe respiratory illnesses in older adults, increasing the risk of hospitalization and complications. By getting vaccinated, older adults can significantly reduce their chances of contracting RSV and protect themselves from the potential health challenges associated with the virus, ultimately promoting a healthier and more active lifestyle in their senior years.

Influenza (High Dose and Regular Dose)
Influenza vaccines come in both high-dose and standard-dose options. The high-dose vaccine contains a higher concentration of antigen, making it more suitable for older adults who may have weaker immune responses. Standard-dose vaccines are generally recommended for most younger and healthy individuals, providing effective protection against seasonal flu strains. Consult with your healthcare provider to determine which option is best for you based on your age and health status.

Shingrix
The shingles vaccine, known as Shingrix, is a highly effective way to prevent shingles, a painful viral infection caused by the reactivation of the chickenpox virus. It is recommended for individuals aged 50 and older, as shingles becomes more common with age. By getting vaccinated, you can significantly reduce the risk of developing shingles and its associated complications, including long-term nerve pain.
*Adults 50 years and older should get two doses of Shingrix, separated by 2 to 6 months*





